MS Niaee, P Namdar, A Allami, L Zolghadr… - Asian Pacific Journal …, 2021 - journals.lww.com
… Several clinical trialstudies have reported the effect of ivermectin on the treatment of COVID-19 patients[ 19 20 ]. The survey of studies on COVID-19 in recent months and ongoing …
… randomized placebo-controlled clinical trial of symptomatic outpatients with COVID-19 not already treated … statement: updated guidelines for reporting parallel group randomizedtrials. …
JO Rahimian, S Yaghi, M Liu, A Lewis… - Research …, 2020 - ncbi.nlm.nih.gov
… A number of randomizedtrials of zinc among COVID-19 patients are currently underway and should provide more definitive data. Second, we did not measure serum zinc levels prior to …
US Perepu, I Chambers, A Wahab, P Ten Eyck… - Journal of Thrombosis …, 2021 - Elsevier
… a multi‐center, open‐label, randomized controlled trial … COVID‐19 and admitted to an intensive care unit (ICU) and/or had laboratory evidence of coagulopathy. Patients were randomly …
F Jaun, M Boesing, G Lüthi-Corridori, K Abig… - Trials, 2022 - Springer
… The study aim is to test the hypothesis that patients with vitamin D deficiency … COVID-19 treated under standardized conditions in hospital will recover faster when additionally treated …
M Shakhsi Niaee, P Namdar, A Allami… - … Pacific Journal Of …, 2021 - search.ebscohost.com
… Several clinical trialstudies have reported the effect of ivermectin on the treatment of COVID-19 patients[19,20]… A randomizedtrial of hydroxychloroquine as postexposure prophylaxis for …
… women with COVID-19 between the ages of 18 and 80 were randomized in the study. The … , diagnosis and treatment of coronavirus infection (COVID-19)". The efficacy and safety of …
S Takayama, T Namiki, T Ito, R Arita, H Nakae… - Trials, 2020 - Springer
… Kampo medicine and conventional treatment will significantly … of treatment as compared with conventional treatment alone. … studies reporting the efficacy of Kampo medicine for COVID-…
… Based on the established safety and tolerability of C21 in healthy subjects and the unprecedented imperative for new and effective treatments of patients with moderate COVID-19, we …